More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.86B
EPS
-1.35
P/E ratio
--
Price to sales
7.85
Dividend yield
--
Beta
1.346069
Previous close
$13.16
Today's open
$13.05
Day's range
$11.76 - $13.06
52 week range
$11.76 - $20.86
show more
CEO
Tom Hogan
Employees
1167
Headquarters
Petah Tikva,
Exchange
Nasdaq Global Select
Shares outstanding
239470062
Issue type
Common Stock
Technology
Software & IT Services
Cellebrite Announces Participation in the Morgan Stanley Technology, Media & Telecom Conference
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 24, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the Company will participate in the upcoming Morgan Stanley Technology, Media & Telecom Conference.
PRNewsWire • 13 hours ago

Cellebrite DI Ltd. (CLBT) Q4 2025 Earnings Call Transcript
Cellebrite DI Ltd. (CLBT) Q4 2025 Earnings Call Transcript
Seeking Alpha • Feb 12, 2026

Cellebrite Announces Record Fourth-Quarter and Full-Year 2025 Results
Total ARR grew 21% to $480.8 million; Revenue grew 18% to $128.8 million Net income of $21.3 million supports non-GAAP net income of $36.7 million and adjusted EBITDA of $38.3 million, 29.8% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 11, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2025.
PRNewsWire • Feb 11, 2026

Cellebrite DI Ltd. (CLBT) Matches Q4 Earnings Estimates
Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.14 per share, in line with the Zacks Consensus Estimate.
Zacks Investment Research • Feb 11, 2026

Cellebrite's 2026 Industry Trends Report Reveals Smartphones as the Leading Source of Digital Evidence in Investigations at 97%
97% cite smartphones as top evidence source, up 24 points from 2024 95% agree digital evidence increases solvability, yet 94% say complexity strains caseloads 65% believe AI can accelerate investigations, but one-third say policies prevent its use Cloud receptiveness hit 42%, yet two-thirds still rely on physical media TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 5, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today unveiled its 2026 Industry Trends Report, which surveyed 1,200 practitioners across 63 countries, marking the company's seventh annual report on how organizations collect, manage and analyze digital evidence.
PRNewsWire • Feb 5, 2026

Artisan Small Cap Fund Q4 2025 Portfolio Activity
During the quarter, we initiated new positions in nLIGHT, Guardant Health and Cellebrite. We also added to Bruker, Hexcel and Penumbra during the quarter. Along with Insmed, we also ended our investment campaigns in Integer Holdings and SharkNinja during the quarter.
Seeking Alpha • Jan 23, 2026

Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2025 financial results before the U.S. markets open on Wednesday, February 11, 2026.
PRNewsWire • Jan 21, 2026

Norwood Investment Partners Opens New $4.3 Million Cellebrite Position
Norwood initiated Cellebrite position and now holds 230,671 shares, worth an estimated $4.27 million. The stake represents 3.68% of 13F reportable assets under management.
The Motley Fool • Dec 9, 2025

Cellebrite: Solid Setup Going Into Next Year
Cellebrite remains a "Buy" as federal demand rebounds and platform adoption accelerates, supporting a strong long-term growth outlook. The federal segment returned to year-over-year growth in Q3, removing the primary bear case and confirming demand was delayed, not lost. Inseyets migration and rapid cloud/SaaS ARR growth—Guardian cloud ARR up >100% for five quarters—position CLBT for outsized ARR acceleration into 2026.
Seeking Alpha • Dec 5, 2025

10 AI Stocks Worth Buying Right Now
Artificial intelligence (AI) will reshape industries for decades, making early positioning in focused AI players critical. Smaller AI companies often offer more upside than megacaps that have already priced in the boom.
The Motley Fool • Dec 4, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Cellebrite DI Ltd. commission-free¹. Build wealth for the long term using automated trading and transfers.